about
Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like CellsIDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway.Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5Curcumin exerts its tumor suppressive function via inhibition of NEDD4 oncoprotein in glioma cancer cells.Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells.Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell LinesAnti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo.Zero-valent Fe confined mesoporous silica nanocarriers (Fe(0) @ MCM-41) for targeting experimental orthotopic glioma in rats.Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls.Centrosomal Protein of 55 Regulates Glucose Metabolism, Proliferation and Apoptosis of Glioma Cells via the Akt/mTOR Signaling Pathway.Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas.Glioblastoma: Overview of Disease and Treatment.Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy.Quantitative Proteomic Profiling of Tachyplesin I Targets in U251 Gliomaspheres.Receptor-Mediated Drug Delivery Systems Targeting to GliomaRottlerin inhibits cell growth and invasion via down-regulation of Cdc20 in glioma cellsHuman Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.d,l-Sulforaphane Induces ROS-Dependent Apoptosis in Human Gliomablastoma Cells by Inactivating STAT3 Signaling Pathway.Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives.Galectin-8 promotes migration and proliferation and prevents apoptosis in U87 glioblastoma cells.CSF1 Overexpression Promotes High-Grade Glioma Formation without Impacting the Polarization Status of Glioma-Associated Microglia and Macrophages.Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells.Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression.Cardamonin induces apoptosis by suppressing STAT3 signaling pathway in glioblastoma stem cells.Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer.Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescenceMicroRNA-141 is a tumor regulator and prognostic biomarker in human glioblastoma.Restoring the oncosuppressor activity of microRNA-34a in glioblastoma using a polyglycerol-based polyplex.The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas.Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity.Subtotal Resection of a Thalamic Glioblastoma Multiforme through Transsylvian Approach.Lesion magnetic susceptibility response to hyperoxic challenge: A biomarker for malignant brain tumor microenvironment?Computational modeling in glioblastoma: from the prediction of blood-brain barrier permeability to the simulation of tumor behavior.Monoamines in Glioblastoma: complex biology with therapeutic potential.Pro-necrotic Activity of Cationic Mastoparan Peptides in Human Glioblastoma Multiforme Cells Via Membranolytic Action.Use of nanoparticles for glioblastoma treatment: a new approach.Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.Identifying survival-associated modules from the dysregulated triplet network in glioblastoma multiforme.
P2860
Q28547244-B9B8D4E3-DBF4-4D83-B12F-02D5E9D132CCQ33709922-1C1E70C7-F40F-468A-BE54-5117AC21E2EDQ33762047-A0DB5D50-C6C8-42DF-95F0-E0CBE64AD0CDQ33893556-70A67134-7477-4177-A614-E60C06B51EBEQ35914670-2DC29874-0D99-44A2-8438-87578EAAF010Q35973580-4C6C63FD-6A08-4108-9C48-3A83F8C94D3CQ35974087-C25B2DA8-5B29-4A32-B29B-0A66CF1F5A5FQ35993525-F3841415-F83E-42A0-8F7C-FE1330BD0FD3Q37076642-FBF3FF1F-DFB6-4B44-918A-EA45F61F7476Q37125964-3A1EFBAD-68B8-4672-AC3C-342394E49E36Q37133643-E1B88D21-9129-4134-ADA0-6B496C993B96Q37314044-71FC13CC-D072-445F-A615-D1E8AEAB2446Q37441791-DED57A7F-EB74-45C4-B7D7-EEEFF1FF5112Q37536491-0E7CADEE-9C5F-4116-BEE8-7ACFD71BC814Q37628648-1EEBC4BF-1839-4EEB-9F5C-528B017547BEQ37636271-9B54BBA1-BD80-440C-893E-E3EAB13B53C3Q37688442-923E6284-609E-438F-AA91-34E61CF2F619Q38390185-ACB84839-6E8E-4521-9DC7-7CAD5E574FFBQ38702642-9F10F82C-6DA9-4B9A-A495-D9663A685127Q38722856-D4834522-C940-4F7C-A476-AC82B43C1062Q38743138-A259D392-FB9A-47BA-A1C7-B43C87AFC98AQ38755698-E42A40F2-BAE8-4AE1-9AFC-39054CA3E0FAQ38783257-937F25CE-3404-4EC2-AEF1-B993D1BE04A9Q38816965-A2B92A86-9359-4C0F-9B3B-0181E693D00DQ38855171-6C49056C-BE39-4E60-A722-2F33D5640E7CQ38856009-2811B351-4E8C-4CE7-9407-8CB24FD4E762Q40901357-570E301C-2DCC-4BB5-AEA2-B6543741FFA4Q41192103-7B7C1B35-6D94-4F63-8E1B-212B28519DDDQ41298452-F4F65F74-FB59-4763-8DBA-B576025E8128Q42119458-C4C55C5F-FE85-4CA2-9537-7452F343FB01Q42370345-7892449A-29AF-4FB2-AAFF-2895D13CD67CQ43960624-56474017-6262-4B5D-9A10-9EEF83D06C67Q47101328-C9B66221-E26D-4BD8-B191-23ADBFC4C0DAQ47267468-98E9C0B0-D69B-46E4-8D51-F0F645C1A0FEQ47319211-49903272-B7AA-4D3A-AED3-C8ABCD3F87A4Q47617131-3F06F68E-41B8-4B0B-8899-1A0E5AEA1088Q47891219-DA873561-8255-40D0-A419-FFDB7206DCADQ48095060-622A6A80-25B1-40BD-B4B2-4EEAC78BCE2AQ48269310-D4333816-788B-43C5-B5BB-980CBA7D326FQ48320688-E9916207-95E1-4DAE-AABF-BDCCA5D12C14
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Glioblastoma multiforme: Pathogenesis and treatment.
@ast
Glioblastoma multiforme: Pathogenesis and treatment.
@en
Glioblastoma multiforme: Pathogenesis and treatment.
@nl
type
label
Glioblastoma multiforme: Pathogenesis and treatment.
@ast
Glioblastoma multiforme: Pathogenesis and treatment.
@en
Glioblastoma multiforme: Pathogenesis and treatment.
@nl
prefLabel
Glioblastoma multiforme: Pathogenesis and treatment.
@ast
Glioblastoma multiforme: Pathogenesis and treatment.
@en
Glioblastoma multiforme: Pathogenesis and treatment.
@nl
P1476
Glioblastoma multiforme: Pathogenesis and treatment
@en
P2093
Dimitrios T Trafalis
P356
10.1016/J.PHARMTHERA.2015.05.005
P577
2015-05-02T00:00:00Z